Botanix Pharmaceuticals Ltd
BOT
Company Profile
Business description
Botanix Pharmaceuticals Ltd is a dermatology company. The company focuses on developing safe and effective topical treatments for serious skin conditions. It has an exclusive license to use a proprietary drug delivery system in all skin diseases. The company's product pipeline includes BTX1503 - Moderate to Severe Acne, BTX1204 - Atopic Dermatitis, and BTX 1702 - Rosacea, Sofdra - Axillary Hyperhidrosis, and others. The majority of Revenue is Derived from Australia.
Contact
41 - 47 Colin Street
Suite 3
West PerthWA6005
AUST: +61 865552945
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
30 June 2025
Employees
1
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,690.90 | 53.40 | 0.62% |
| CAC 40 | 7,737.20 | 14.69 | -0.19% |
| DAX 40 | 23,930.67 | 66.81 | -0.28% |
| Dow JONES (US) | 42,305.48 | 35.41 | 0.08% |
| FTSE 100 | 8,774.26 | 1.88 | 0.02% |
| HKSE | 23,488.28 | 330.31 | 1.43% |
| NASDAQ | 19,242.61 | 128.85 | 0.67% |
| Nikkei 225 | 37,496.55 | 25.88 | 0.07% |
| NZX 50 Index | 12,327.23 | 91.66 | -0.74% |
| S&P 500 | 5,935.94 | 24.25 | 0.41% |
| S&P/ASX 200 | 8,466.70 | 52.60 | 0.63% |
| SSE Composite Index | 3,362.10 | 14.61 | 0.44% |